Short Interest in Aptorum Group Limited (NASDAQ:APM) Increases By 27.9%

Aptorum Group Limited (NASDAQ:APMGet Rating) was the recipient of a significant growth in short interest during the month of August. As of August 31st, there was short interest totalling 122,900 shares, a growth of 27.9% from the August 15th total of 96,100 shares. Currently, 1.3% of the shares of the stock are sold short. Based on an average trading volume of 112,600 shares, the short-interest ratio is currently 1.1 days.

Aptorum Group Stock Down 7.2 %

Shares of NASDAQ:APM opened at $1.42 on Friday. The business’s 50 day moving average price is $1.47 and its 200-day moving average price is $1.35. Aptorum Group has a 1 year low of $0.86 and a 1 year high of $2.82.

About Aptorum Group

(Get Rating)

Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A.

Recommended Stories

Receive News & Ratings for Aptorum Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptorum Group and related companies with MarketBeat.com's FREE daily email newsletter.